Topical Steroid Withdrawal: a survey of UK dermatologists' attitudes.
Richard BarlowAndrew ProctorCelia MossPublished in: Clinical and experimental dermatology (2024)
The term topical steroid withdrawal (TSW) refers to a condition widely discussed on social media, but rarely mentioned in the medical literature. It typically involves a patient with chronic eczema who abruptly discontinues topical corticosteroids (TCS) believing they are ineffective and damaging. Symptoms include an acute eruption, worse than the previous eczema, of painful erythema followed by oozing, crusting, desquamation and sometimes prolonged weakness. Patients self-diagnose and often avoid healthcare professionals who dismiss the diagnosis and persist in offering TCS, leaving them unsupported. We analysed 121 responses to a survey of UK dermatologists' attitudes to TSW. Views on aetiology included relapsed eczema, erythroderma and a social construct. Eighty-eight percent agreed that TSW needs better understanding and more research. Respondents earlier in their careers are more cautious than seniors about prescribing TCS long-term because of TSW, suggesting a trend that might lead to better understanding, communication and management.
Keyphrases
- social media
- mental health
- healthcare
- atopic dermatitis
- end stage renal disease
- ejection fraction
- newly diagnosed
- health information
- primary care
- systematic review
- liver failure
- preterm infants
- cross sectional
- acute lymphoblastic leukemia
- prognostic factors
- case report
- acute myeloid leukemia
- drug induced
- diffuse large b cell lymphoma
- respiratory failure
- multiple myeloma
- hodgkin lymphoma
- intensive care unit
- depressive symptoms
- sleep quality